| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/07/2005 | CN1664097A Expression of Hypoderm A (HA) in pastoris system and use thereof |
| 09/07/2005 | CN1218044C Method for producing protein hydrolysate |
| 09/07/2005 | CN1217956C Soluble single-chain T-cell receptor proteins |
| 09/06/2005 | US6939959 Efficient protein expression system |
| 09/06/2005 | US6939956 Variable region of the monoclonal antibody against HBV S-surface antigen and a gene encoding the same |
| 09/06/2005 | US6939951 G protein coupled receptors solubilized in two successive detergents; alkylglycosides, glycoside, monosaccharides, disaccharides, alkylphosphorylcholines; production into native or active structure |
| 09/06/2005 | US6939949 Protein for use in diagnosis and treatment of cancer |
| 09/06/2005 | US6939711 Control of gene expression in plants by receptor mediated transactivation in the presence of a chemical ligand |
| 09/06/2005 | US6939693 Enantioselective oligomerization of α-hydroxy carboxylic acids and α-amino acids |
| 09/06/2005 | US6939678 Methods for the assay of troponin I and T and complexes of troponin I and T and selection of antibodies for use in immunoassays |
| 09/06/2005 | US6939543 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 09/06/2005 | CA2250693C Compositions and methods for taxol biosynthesis |
| 09/01/2005 | WO2005080986A1 Antibodies to phosphorylated tau, methods of making and methods of use |
| 09/01/2005 | WO2005080586A1 Fusion proteins containing recombinant cytotoxic rnases |
| 09/01/2005 | WO2005080555A1 Monoclonal antibody specific to cell surface protein of human embroyonic stem cell |
| 09/01/2005 | WO2005080550A1 Lactic acid with high nisin-productivity and method of selecting the same |
| 09/01/2005 | WO2005080545A2 Method for the production of recombined proteins in eukaryontic host cells |
| 09/01/2005 | WO2005080435A1 Monoclonal antibody and use thereof |
| 09/01/2005 | WO2005080420A2 Hyphal growth in fungi |
| 09/01/2005 | WO2005080419A1 Polypeptide agent for inhibiting sars coronavirus and its derivatives and use thereof |
| 09/01/2005 | WO2005079267A2 Methods for protein production |
| 09/01/2005 | WO2005079232A2 A METHOD FOR THE PRODUCTION OF AN ERYTHROPOIETIN ANALOG-HUMAN IgG FUSION PROTEINS IN TRANSGENIC MAMMAL MILK |
| 09/01/2005 | WO2004024076A8 Novel compositions and methods for the treatment of immune related diseases |
| 09/01/2005 | WO2002083873A3 Enzymes |
| 09/01/2005 | US20050191736 Polypeptides having cellulolytic enhancing activity andpolynucleotides encoding same |
| 09/01/2005 | US20050191733 Nucleotide sequences coding glucose transport protein for use in enhancement of foods, cosmetic and animal feeds |
| 09/01/2005 | US20050191729 Methods for the recombinant production of antifusogenic peptides |
| 09/01/2005 | US20050191727 Modified viral sequences which enhance genic expression in microorganismal host |
| 09/01/2005 | US20050191725 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/01/2005 | US20050191720 A vector for the surface expression of antibiotics composed of one or more genes that encode the synthetase and a gene encoding an amphiphilic peptide antibiotic having antibacterial, antifungal and anticancer activities; lactic acid-forming bacteria transformed with the vector |
| 09/01/2005 | US20050191712 immunoassay of acidic repeat protein/immunogens; solid phase synthesis; kits for diagnosis of syphilis |
| 09/01/2005 | US20050191711 Cerebral amyloid plaque precursors for use as diagnostic tool in detection of nervous system disorders |
| 09/01/2005 | US20050191710 Method for labeling a membrane-localized protein |
| 09/01/2005 | US20050191703 Bioassy for identifying compounds which prevent host proteins interation with viral protein associated with infection, replication, assembly or release; viricides |
| 09/01/2005 | US20050191696 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products |
| 09/01/2005 | US20050191690 Membrane proteins for identifying modulators for prevention and treatment of infection, cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory and metabolic disorders |
| 09/01/2005 | US20050191689 Novel nucleic acid base pair |
| 09/01/2005 | US20050191673 Nucleotide sequences coding tumor marker genes for use as tool in classification, diagnosis and prognosis of cell proliferative disorders |
| 09/01/2005 | US20050191650 Used to reduce body temperature, suppress appetite, and therapy or prophylaxis of congestive heart failure and various stress-related disorders |
| 09/01/2005 | US20050191649 Identifying mutation in oligoadenylate synthetase gene (OAS1); identifying modulators for prevention and treatment of cell proliferative, nervous system and diabetic disorders |
| 09/01/2005 | US20050191648 Computer-directed assembly of a polynucleotide encoding a target polypeptide |
| 09/01/2005 | US20050191316 Neisseria genomic sequences and methods of their use |
| 09/01/2005 | US20050191301 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 09/01/2005 | DE102004007658A1 Verfahren zur Herstellung von rekombinanten Proteinen in eukaryontischen Wirtszellen A process for the production of recombinant proteins in eukaryotic host cells |
| 09/01/2005 | CA2788707A1 Compositions and methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells |
| 09/01/2005 | CA2557424A1 Methods for protein production |
| 09/01/2005 | CA2555972A1 Hyphal growth in fungi |
| 09/01/2005 | CA2555661A1 Fusion proteins containing recombinant cytotoxic rnases |
| 08/31/2005 | EP1568772A2 Human growth hormone variants |
| 08/31/2005 | EP1568771A2 Human growth hormone variants |
| 08/31/2005 | EP1568710A2 Antibody purification method |
| 08/31/2005 | EP1568708A2 Methods and medical uses of nucleic acids encoding a TRAF inhibitor |
| 08/31/2005 | EP1568707A1 Antihypertensive peptides from casein hydrolysates |
| 08/31/2005 | EP1567868A2 Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines |
| 08/31/2005 | EP1567659A2 Method for continuous, automated blending of solutions from acids and bases |
| 08/31/2005 | EP1567657A1 Process for purifying a fermentation-derived product |
| 08/31/2005 | EP1567556A2 Recombinant immunotoxin and use in treating tumors |
| 08/31/2005 | EP1484959A4 Nucleic acid constructs and methods for producing altered seed oil compositions |
| 08/31/2005 | EP1254247B1 Protein and oat beta glucan hydrolysate for use in cosmetology and method for making same |
| 08/31/2005 | EP1078064B1 Compounds from moraxella catarrhalis |
| 08/31/2005 | EP0939653B1 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications |
| 08/31/2005 | EP0721345B1 Prostatic cancer vaccine |
| 08/31/2005 | CN1662657A Low-cost production of peptides |
| 08/31/2005 | CN1662558A Antibodies specific for human cd22 and their therapeutic anddiagnostic uses |
| 08/31/2005 | CN1662254A ALCAM and ALCAM modulators |
| 08/31/2005 | CN1661038A Method for preparing protein polypeptide through enzymolysis of cow milk |
| 08/31/2005 | CN1661037A Method for preparing recombined thymosin alpha 1 |
| 08/31/2005 | CN1661036A Method for preparing interferon of white blood cells of dogs |
| 08/31/2005 | CN1661035A Method for preparing leukocyte interferon of pig |
| 08/31/2005 | CN1661034A Method for producing dipeptide |
| 08/31/2005 | CN1661033A Integrated production method of protein fermentation |
| 08/31/2005 | CN1661032A Method of hydrolyzing protein through enzyme |
| 08/31/2005 | CN1661031A Method for enzyme hydrolyzing zein through two steps method |
| 08/31/2005 | CN1661019A Method for producing recombined endothelium chalone in bacillus colis and application |
| 08/31/2005 | CN1661015A Glutathione synthetase-coding gene of candida utilis |
| 08/31/2005 | CN1661012A Miniaturized polypeptide of anti EB Virus tumour, application and preparation method |
| 08/31/2005 | CN1660913A Immunoassays for anti-HCV antibodies |
| 08/31/2005 | CN1660909A Neutralization monoclonal antibody of white spot syndrome virus and preparation method |
| 08/31/2005 | CN1660907A Monoclonal antibody of anti lymphocyst virus of and preparation method |
| 08/31/2005 | CN1660899A GP thymosin alpha 1 and preparation method |
| 08/31/2005 | CN1660894A New type antibiotic peptide of peptaibol and preparing technique |
| 08/31/2005 | CN1660892A Oxidation resistant bioactive peptide of halobios and preparation method |
| 08/31/2005 | CN1660888A Peptide of decreasing blood pressure of protein of acetes chinensis, preparing method and application |
| 08/31/2005 | CN1217000C Exhiting method of preparing antibody by antigen utilizing bacteriophage exhibiting technique |
| 08/31/2005 | CN1216992C Immunomodulators |
| 08/31/2005 | CN1216991C Human guanosine monophophate reductase and its coding sequence and preparation method |
| 08/31/2005 | CN1216990C Plant promoter and gene expression with the use of the same |
| 08/31/2005 | CN1216910C Novel liver regeneration related protein, its code sequence and application |
| 08/31/2005 | CN1216901C Method for cleaving chimeric protein using processing enzyme |
| 08/30/2005 | US6936704 a nucleotide sequence which hybridizes to the complement of the specific nucleic acid molecule over its full length under conditions of incubation and encodes a polypeptide which costimulates T cell proliferation in vitro |
| 08/30/2005 | US6936698 Genetically engineered immunoglobulin; for use in treatment of hematopoietic defects |
| 08/30/2005 | US6936695 Manufacture and expression of large structural genes |
| 08/30/2005 | US6936694 [Met--1, des-Cys1, des-Tyr2, des-Cys3]IFN- gamma polypeptide produced by a DNA sequence coding in a transformant organism, and such polypeptide having the characteristics of human immune interferon |
| 08/30/2005 | US6936693 Specific polypeptides, useful as nematocides |
| 08/30/2005 | US6936692 Binding antibodies; culture product; gene therapy; chromosome mapping |
| 08/30/2005 | US6936691 Secreted protein HCE3C63 |
| 08/30/2005 | US6936688 Nucleotide sequences coding polypeptide for use in the treatment of leukemia, tumors, infections, autoimmune disease, and fibrotic disorders; wound healing agent |
| 08/30/2005 | US6936455 heterologous polypeptide is initially expressed in the form of cytoplasmic inclusion bodies in the host cell, the inclusion bodies are isolated and subsequently treated so that the desired heterologous polypeptide is cleaved autoproteolytically |
| 08/30/2005 | US6936449 Regulatable growth of filamentous fungi |
| 08/30/2005 | US6936440 Selecting ligand agonists and antagonists |